STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation

April 9, 2026 updated by: Weidong Tong, Third Military Medical University

STOPS Trial: A Multicentre Prospective Randomised Clinical Trial Comparing Total Colectomy With Ileorectal Anastomosis Versus Subtotal Colectomy With Cecal-rectal Anastomosis for Slow Transit Constipation

Total colectomy with ileorectal anastomosis is a traditional surgical option for slow transit constipation (STC). Subtotal colectomy with caecorectal anastomosis have been reported to be a potential alternative approach. Thus, the optimal surgical option for STC is controversial.

Study Overview

Detailed Description

Constipation, a prevalent gastrointestinal disorder, affects 10%-15% of adults in the United States and approximately 8.2% of China's general population. Slow transit constipation (STC), accounting for 15%-42% of constipation cases, is characterized by impaired colonic motility. For patients refractory to conservative therapies who experience chronic, intractable symptoms and diminished quality of life (QoL), surgical intervention becomes the last-resort treatment. The primary surgical approach for STC has historically been total colectomy with ileorectal anastomosis (TC-IRA). Over the past two decades, however, subtotal colectomy with cecorectal anastomosis (SC-CRA) has garnered growing interest within the surgical community due to its potential to mitigate postoperative diarrhea. Despite this benefit, SC-CRA raises concerns about an elevated risk of recurrent constipation. The debate regarding the superiority of these approaches remains unresolved. This study aims to address this controversy through a comparative analysis of TC-IRA and SC-CRA, evaluating their therapeutic efficacy and safety profiles in refractory STC.

Study Type

Interventional

Enrollment (Actual)

252

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Chongqing Municipality
      • Yuzhong, Chongqing Municipality, China, 400042
        • Army Medical Center (Daping Hospital)
    • Gansu
      • Lanzhou, Gansu, China, 730050
        • No. 940 Hospital of Joint Logistics Support Force of Chinese People's Liberation Army
    • Hubei
      • Wuhan, Hubei, China, 430060
        • Renmin Hospital of Wuhan University
      • Wuhan, Hubei, China, 430062
        • Zhongnan Hospital of Wuhan University
    • Jiangsu
      • Nanjing, Jiangsu, China, 210002
        • General Hospital of the Eastern Theater Cammand of the PLA
    • Liaoning
      • Shengyang, Liaoning, China, 110001
        • The First Hospital of China Medical University
    • Shandong
      • Qingdao, Shandong, China, 266011
        • Qingdao Municipal Hospital
    • Shanghai Municipality
      • Pudong, Shanghai Municipality, China, 200127
        • Renji Hospital, Shanghai Jiaotong University
      • Pudong, Shanghai Municipality, China, 201299
        • Shanghai Pudong New Area People's Hospital
    • Shanxi
      • Xi’an, Shanxi, China, 710032
        • Xijing Hospital
    • Sichuan
      • Chengdu, Sichuan, China, 610036
        • The General Hospital of Western Theater Command
      • Chengdu, Sichuan, China, 610017
        • Chengdu Analrectal Hospital
      • Yibin, Sichuan, China, 644000
        • The Second People's Hospital of Yibin
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310014
        • Zhejiang Provincial People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion criteria

  1. Patients (≥18 years of age) of either sex
  2. Patients with conditions in agreement with the Roman IV criteria of functional constipation
  3. Patients have less than one complete spontaneous bowel movement per week
  4. Patients rely on laxatives to assist defecation for a long time
  5. More than 20% the radio-paque markers localized in the colon after 72 hours based on colonic transit studies
  6. Patients were refractory to conservative treatment for more than 1 year
  7. Patients with a strong desire for surgery

Exclusion criteria

  1. Pregnant or breast-feeding women
  2. Patients with megacolon, megarectum,severe spastic constipation, severe rectocele, rectal prolapse (Oxford Grade IV or above)
  3. Patients with colorectal neoplasms
  4. Patients with small intestinal slow transit
  5. Patients with constipation-predominant irritable bowel syndrome
  6. Patients with inflammatory bowel disease
  7. Patients with ileostomy
  8. Patients with severe psychiatric disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Total colectomy with ileorectal anastomosis
Total colectomy with ileorectal anastomosis (TC-IRA) serves as the standard surgical treatment for slow transit constipation.
Following complete colonic mobilization without preservation of the ileocolic vascular pedicle, the surgical specimen was extracted by extending the right lower quadrant trocar incision to approximately 4-5 cm. A resection of ileum, 2-3 cm proximal to the ileocecal junction, will be conducted by stapler. The anvil of a 29-mm circular stapler was inserted into the proximal ileal lumen and repositioned intra-abdominally. Ileorectal anastomosis was performed by transanal insertion of the circular stapler, aiming to achieve a tension-free, contamination-minimized reconstruction. Finally, a closed suction drain was placed in the rectouterine pouch (Douglas pouch), and all abdominal incisions were closed in layers.
Experimental: Subtotal colectomy with cecal-rectal anastomosis
Subtotal colectomy with cecorectal anastomosis (SC-CRA) is selectively employed for slow transit constipation.
Following complete colonic mobilization with preservation of the ileocolic vascular pedicle and its branches, the surgical specimen was extracted by extending the right lower quadrant trocar incision to 4-5 cm. After insertion of the anvil from a 29-mm circular stapler through the ascending colon resection margin, a resection about 3 cm distal to the ileocecal junction will be conducted. The cecum was then positioned in the pelvis without rotational torsion, and an antiperistaltic cecorectal anastomosis was created between cecal fundus (after appendectomy) and the rectal stump. The anastomosis was performed via transanal insertion of the circular stapler to ensure tension-free, contamination-controlled reconstruction. Finally, a closed suction drain was placed in the rectouterine pouch (Douglas pouch), and all abdominal incisions were closed in a layered fashion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wexner Constipation Score
Time Frame: From the pre-operation to 36 months following surgery
The Wexner Constipation Score will be recorded in terms of scores. Questions examine constipation in its clinical expressions. Each question is answered on a scale of 0 to 4. The scale ranges from 0 (best) to 30 (worst)
From the pre-operation to 36 months following surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastrointestinal Quality of Life Index
Time Frame: From the pre-operation to 36 months following surgery
Gastrointestinal Quality of Life Index will be recorded in terms of scores. There are The four possible answers to every question, scored from 0 points (worst) to 4 points (best). The final sum ranges from 0(worst) to 144(best).
From the pre-operation to 36 months following surgery
36-item short-form health survey
Time Frame: From the pre-operation to 36 months following surgery
There are eight spheres in the SF-36 survey, including physical function, role physical, role emotional, physical pain, vitality, mental health, social function and general health. Results of each sphere will be recorded in terms of scores. Once the questionnaire was applied to the patients, a summary calculation and a linear transformation were performed to obtain a score within a scale from 0(worst) to 100(best).
From the pre-operation to 36 months following surgery
The incidence of complications
Time Frame: From the pre-operation to 36 months following surgery
Postoperative complications includes short-term and long-term complications, such as ileus, anastomotic leak, small intestinal obstruction, constipation recurrence and so on. Number of Participants with complications will be recorded.
From the pre-operation to 36 months following surgery
The number of bowel movements per week
Time Frame: From the pre-operation to 36 months following surgery
The number of bowel movements will be recorded in terms of times per week.
From the pre-operation to 36 months following surgery
Wexner's incontinence score
Time Frame: From the pre-operation to 36 months following surgery
The Wexner's incontinence score will be recorded in terms of scores. the sacles have 5 items to quantify incontinence grade and frequency and its effect on ordinary life. Each question is answered on a scale of 0 to 4, the global score ranging from 0 (best) to 20 (worst).
From the pre-operation to 36 months following surgery
The incidence of abdominal pain
Time Frame: From the pre-operation to 36 months following surgery
The incidence of abdominal pain will be recorded in terms of percent. no special measurement is needed.
From the pre-operation to 36 months following surgery
The incidence of bloating
Time Frame: From the pre-operation to 36 months following surgery
The incidence of bloating will be recorded in terms of percent
From the pre-operation to 36 months following surgery
The incidence of diarrhea
Time Frame: From the pre-operation to 36 months following surgery
The incidence of diarrhea will be recorded in terms of percent.
From the pre-operation to 36 months following surgery
The incidence of straining
Time Frame: From the pre-operation to 36 months following surgery
The incidence of straining will be recorded in terms of percent.
From the pre-operation to 36 months following surgery
The incidence of laxative use
Time Frame: From the pre-operation to 36 months following surgery
The incidence of laxative use will be recorded in terms of percent.
From the pre-operation to 36 months following surgery
The incidence of enema use
Time Frame: From the pre-operation to 36 months following surgery
The incidence of enema use use will be recorded in terms of percent.
From the pre-operation to 36 months following surgery
Intraoperative measures
Time Frame: Perioperative period
Operation time (minutes), blood loss (mL), complications (classified according to Clavien-Dindo) for both study groups.
Perioperative period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Weidong Tong, MD, Army Medical Center (Daping Hospital)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2022

Primary Completion (Actual)

May 1, 2025

Study Completion (Estimated)

May 1, 2028

Study Registration Dates

First Submitted

April 3, 2022

First Submitted That Met QC Criteria

April 23, 2022

First Posted (Actual)

April 28, 2022

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Total colectomy with ileorectal anastomosis

Subscribe